GlassScriptPhysician profile
Maricarmen Quintero
NPI 1629064456
$13,286.85
in general payments reported to CMS, 2019-2025
34 companies · $2,597 in 2025
The $2,597 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,985 · 2020: $432 · 2021: $1,145 · 2022: $2,336 · 2023: $2,206 · 2024: $2,586 · 2025: $2,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,389.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,009.66 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,738.23 | 2019-2025 | |
| Amgen INC. | $1,471.83 | 2019-2025 | Evenity, Enbrel, Krystexxa |
| Janssen Biotech, INC. | $1,143.72 | 2019-2025 | Tremfya, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $1,003.19 | 2019-2025 | Orencia, Sotyktu |
| Pfizer INC. | $823.62 | 2019-2025 | |
| Glaxosmithkline, LLC. | $817.09 | 2019-2025 | Benlysta, Nucala |
| Ucb, INC. | $707.86 | 2019-2025 | Cimzia, Bimzelx |
| Horizon Therapeutics Plc | $491.47 | 2019-2023 | Krystexxa |
| Radius Health, INC. | $463.53 | 2019-2025 | Tymlos |
| Mallinckrodt Hospital Products INC. | $193.28 | 2023-2025 | Acthar |
| Genentech USA, INC. | $182.95 | 2019-2024 | Actemra |
| Lilly USA, LLC | $179.66 | 2019-2024 | Taltz |
| Aurinia Pharma U.S., INC. | $137.33 | 2022-2025 | Lupkynis |
| Astrazeneca Pharmaceuticals LP | $135.03 | 2022-2025 | Saphnelo |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.68 | 2022-2024 | Ofev |
| Alvogen INC | $110.68 | 2022-2024 | Teriparatide |
| Actelion Pharmaceuticals US, INC. | $87.66 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $61.35 | 2024-2025 | Purified Cortrophin Gel |
| Kiniksa Pharmaceuticals International, Plc | $47.05 | 2024 | Arcalyst |
| Genzyme Corporation | $41.39 | 2019-2025 | |
| Smith+Nephew, INC. | $40.49 | 2024 | Or3o Dual Mobility, Real Intelligence |
| Fresenius Kabi USA, LLC | $39.92 | 2024 | Idacio |
| Sobi, INC | $34.22 | 2019-2022 | |
| Organon LLC | $31.92 | 2022-2023 | Hadlima |
| Ultragenyx Pharmaceutical INC. | $24.60 | 2023 | Crysvita |
| Fidia Pharma USA INC. | $23.29 | 2023 | Hymovis |
| Kiniksa Pharmaceuticals, LTD. | $23.00 | 2023 | Arcalyst |
| Alexion Pharmaceuticals, INC. | $21.73 | 2022 | |
| Depuy Synthes Sales INC. | $15.91 | 2021 | |
| Novo Nordisk INC | $15.58 | 2023 | Wegovy |
| Kowa Pharmaceuticals America, INC. | $15.03 | 2022 | |
| Medexus Pharma, INC. | $12.23 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maricarmen Quintero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.